Log in or Sign up for Free to view tailored content for your specialty!
Leukemia News
Specialist follow-up may be unnecessary for low-risk chronic leukemia
Individuals with low-risk chronic lymphocytic leukemia who exhibit no symptoms may no longer require specialized follow-up, according to study data published in Blood Advances.
‘All-in-one’ CAR-T, stem cell transplantation induces remission in advanced leukemia
A sequential chimeric antigen receptor T-cell therapy and haploidentical hematopoietic stem cell transplantation strategy conferred remissions in certain patients with relapsed or refractory CD7-positive hematologic cancers.
Value of MRI, lumbar puncture questioned for immune cell-associated neurotoxicity syndrome
MRIs and lumbar punctures may not provide enough therapeutic value to be standard-of-care diagnostic tests in patients suffering neurologic symptoms following chimeric antigen receptor T-cell therapy.
Log in or Sign up for Free to view tailored content for your specialty!
National Comprehensive Cancer Network appoints board of directors chair, vice chair
Matt Kalaycio, MD, FACP, has been elected chair of National Comprehensive Cancer Network’s board of directors.
Combining genomics, drug sensitivity testing could be ‘invaluable’ cancer treatment tool
An innovative combination of drug sensitivity testing and genomics helped identify therapeutic options for children with relapsed or refractory solid or hematologic malignancies, according to results published in Nature Medicine.
Parents of children with cancer more often seek help for anxiety, depression
Parents of children with cancer made mental health visits, including those for anxiety and depression, significantly more often than other parents, according to results published in JAMA Network Open.
Longer exclusive breastfeeding may lower hematologic cancer risk for children
Exclusive breastfeeding for at least 3 months was associated with reduced childhood hematologic cancer risk vs. shorter breastfeeding durations, according to cohort study results published in JAMA Network Open.
Elderly experience ‘impressive improvement’ in survival after stem cell transplant
Among elderly patients with acute myeloid leukemia, survival outcomes for those who received an allogenic stem cell transplant have improved significantly over the past 2 decades, according to data published in Clinical Cancer Research.
‘Wake-up call’: Cardiovascular toxicity a concern for patients receiving bispecifics
More than 20% of reported cases of adverse events following bispecific T-cell engager therapies involved a cardiovascular event, findings reported in Journal for ImmunoTherapy of Cancer showed.
Most U.S. cancer trials conducted in more affluent, less diverse areas
Most of the major cancer clinical trial centers in the U.S. are located near more affluent and white populations compared with the national average, according to results published in JAMA Oncology.
-
Headline News
Q&A: FDA confirms traces of bird flu virus in pasteurized milk
April 25, 20244 min read -
Headline News
Climbing stairs reduces risk for all-cause, cardiovascular death
April 26, 20241 min read -
Headline News
Children show poor asthma outcomes in high environmental injustice areas in Atlanta
April 25, 20243 min read
-
Headline News
Q&A: FDA confirms traces of bird flu virus in pasteurized milk
April 25, 20244 min read -
Headline News
Climbing stairs reduces risk for all-cause, cardiovascular death
April 26, 20241 min read -
Headline News
Children show poor asthma outcomes in high environmental injustice areas in Atlanta
April 25, 20243 min read